ROR1 is a novel putative druggable target for diffuse glioma

Miya John, Padmashree Rao, Humaira Noor, Caroline Ford
doi: https://doi.org/10.1101/2021.12.03.21267166

Article usage

Article usage: December 2021 to January 2025

AbstractFullPdf
Dec 2021333483
Jan 202255515
Feb 202234030
Mar 202252116
Apr 202235016
May 202243037
Jun 202225036
Jul 202225010
Aug 20222213
Sep 202235017
Oct 202230010
Nov 20222429
Dec 20222508
Jan 20231508
Feb 20231427
Mar 20231905
Apr 202322115
May 202319212
Jun 20231046
Jul 2023913
Aug 2023191410
Sep 202315511
Oct 20231329
Nov 20231633
Dec 20231619
Jan 20241237
Feb 20241141
Mar 20241737
Apr 20241065
May 20241259
Jun 2024912
Jul 20241458
Aug 20241184
Sep 20241037
Oct 2024983
Nov 2024817
Dec 2024924
Jan 2025102
Back to top
Posted December 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
ROR1 is a novel putative druggable target for diffuse glioma
Miya John, Padmashree Rao, Humaira Noor, Caroline Ford
medRxiv 2021.12.03.21267166; doi: https://doi.org/10.1101/2021.12.03.21267166
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area